Lombard Odier Asset Management (USA)’s Kindred Biosciences, Inc. KIN Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-92,434	Closed	-$660K	–	222
2015 Q1	$660K	Sell	92,434 -7,566	-8%	-$52.1K	0.05%	160
2014 Q4	$745K	Buy	100,000 +25,040	+33%	+$212K	0.05%	163
2014 Q3	$693K	Buy	74,960 +24,960	+50%	+$337K	0.05%	171
2014 Q2	$932K	Buy	+50,000	New	+$849K	0.05%	161

Other funds holding KIN

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s KIN Position: Q2 2015 in Review

Lombard Odier Asset Management (USA) sold out of Kindred Biosciences, Inc. (KIN) in Q2 2015, closing a stake of 92,434 shares — an estimated $660K sold.

Lombard Odier Asset Management (USA) first reported a position in KIN in Q2 2014 and held it in 4 quarters. The position peaked at $932K in Q2 2014. 57 funds tracked by Wall St. Rank hold KIN as of Q2 2015.

Lombard Odier Asset Management (USA) reported no remaining Kindred Biosciences, Inc. position as of Q2 2015 after selling out during the quarter.
Lombard Odier Asset Management (USA) sold 92,434 Kindred Biosciences, Inc. shares in Q2 2015, an estimated $660K.
Lombard Odier Asset Management (USA) first reported a position in Kindred Biosciences, Inc. in Q2 2014 and held it in 4 quarters.
Lombard Odier Asset Management (USA)'s Kindred Biosciences, Inc. position peaked at $932K in Q2 2014.
57 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q2 2015.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q2 2015, filed 14 Aug 2015.